MTOR and tuberculosis: Data from the 2014 research article by Singhal et al. suggest that metformin, which is an FDA approved-AMPK modulator and mTOR-independent autophagy activator, inhibits intracellular growth of Mtb and enhances the efficacy of conventional anti-TB drugs in mice models.